/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

SAB Biotherapeutics Inc Share Price Today: Live Updates & Key Insights

SAB Biotherapeutics Inc share price today is $3.81, up -0.79%. The stock opened at $3.78 against the previous close of $3.78, with an intraday high of $3.8373 and low of $3.71.

SAB Biotherapeutics Inc Share Price Chart

style
pb-0

SAB Biotherapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

SAB Biotherapeutics Inc Share Price Performance

$3.81 -0.0079(-0.79%) SABS at 23 Mar 2026 03:06 PM Biotechnology
Lowest Today 3.71
Highest Today 3.8373
Today’s Open 3.78
Prev. Close 3.78
52 Week High 5.15
52 Week Low 1.00
Day’s Range: Low 3.71 High 3.8373
52-Week Range: Low 1.00 High 5.15
1 day return -
1 Week return -5.32
1 month return +1.91
3 month return -2.86
6 month return +48.01
1 year return +164.53
3 year return -26.86
5 year return -96.21
10 year return -

SAB Biotherapeutics Inc Institutional Holdings

Vivo Capital, LLC 23.99

COMMODORE CAPITAL LP 9.24

RA Capital Management, LLC 9.24

Woodline Partners LP 5.99

Spruce Street Capital LP 4.62

Sessa Capital, L.P 4.62

Vanguard Group Inc 3.88

Vanguard Total Stock Mkt Idx Inv 3.45

Propel Bio Management LLC 1.37

Balyasny Asset Management LLC 1.00

Millennium Management LLC 0.68

HB Wealth Management, LLC 0.65

Marshall Wace Asset Management Ltd 0.50

Simplify Asset Management Inc. 0.44

Simplify Propel Opportunities ETF 0.44

Awm Investment Company Inc 0.42

StemPoint Capital LP 0.31

Geode Capital Management, LLC 0.25

Vanguard Institutional Extnd Mkt Idx Tr 0.16

A4Investments SICAV SIF ACCI IlanaA2EURH 0.16

Pathstone Holdings LLC 0.11

Fidelity Extended Market Index 0.10

Omers Administration Corp 0.09

Fidelity Nasdaq Composite Index 0.07

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Qube Research & Technologies 0.07

Vanguard Instl Ttl Stk Mkt Idx InstlPls 0.06

Verition Fund Managegment, LLC 0.06

Vanguard Balanced Index Inv 0.05

Avantis US Small Cap Equity ETF 0.05

NT Ext Equity Mkt Idx Fd - L 0.03

Fidelity Total Market Index 0.03

Fidelity Series Total Market Index 0.02

Spartan Extended Market Index Pool F 0.02

Northern Trust Extended Eq Market Idx 0.02

Spartan Total Market Index Pool G 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

Blackrock Extended Mkt Fund CF 0.01

Extended Equity Market Fund K 0.01

NT Ext Equity Mkt Idx Fd - NL 0.00

SAB Biotherapeutics Inc Market Status

Strong Buy: 4

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

SAB Biotherapeutics Inc Fundamentals

Market Cap 191.07 M

PB Ratio 1.2578

PE Ratio 0.0

Enterprise Value 99.92 M

Total Assets 172.81 M

Volume 1328280

SAB Biotherapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:23904181 23.9M, FY21:60876078 60.9M, FY20:55237759 55.2M, FY19:3441807 3.4M

Annual Profit FY23:null 0.0M, FY22:23904181 23.9M, FY21:60876078 60.9M, FY20:55237759 55.2M, FY19:3441807 3.4M

Annual Net worth FY23:-27211618 -27.2M, FY22:-18740804 -18.7M, FY21:-17444478 -17.4M, FY20:20117773 20.1M, FY19:-9417359 -9.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:263137 0.3M

Quarterly Profit Q3/2025:-765469 -0.8M, Q2/2025:-822000 -0.8M, Q1/2025:-778301 -0.8M, Q3/2024:null 0.0M, Q2/2024:-758863 -0.8M

Quarterly Net worth Q3/2025:45445469 45.4M, Q2/2025:-10114270 -10.1M, Q1/2025:-5196773 -5.2M, Q3/2024:-10349410 -10.3M, Q2/2024:-7335455 -7.3M

About SAB Biotherapeutics Inc & investment objective

Company Information SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Organisation Biotechnology

Employees 86

Industry Biotechnology

CEO Mr. Samuel J. Reich

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

SAB Biotherapeutics Inc FAQs

What is the share price of SAB Biotherapeutics Inc today?

The current share price of SAB Biotherapeutics Inc is $3.81.

Can I buy SAB Biotherapeutics Inc shares in India?

Yes, Indian investors can buy SAB Biotherapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy SAB Biotherapeutics Inc shares in India?

You can easily invest in SAB Biotherapeutics Inc shares from India by:

Can I buy fractional shares of SAB Biotherapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SAB Biotherapeutics Inc?

SAB Biotherapeutics Inc has a market cap of $191.07 M.

In which sector does SAB Biotherapeutics Inc belong?

SAB Biotherapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in SAB Biotherapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of SAB Biotherapeutics Inc?

The PE ratio of SAB Biotherapeutics Inc is N/A and the PB ratio is 1.26.